Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CERE - Cerevel Therapeutics GAAP EPS of -$0.40

CERE - Cerevel Therapeutics GAAP EPS of -$0.40

Ceres Inc.
Cerevel Therapeutics press release (NASDAQ:CERE): Q4 GAAP EPS of -$0.40. Cash, cash equivalents and marketable securities as of December 31, 2021, were $618.0 million, compared to $383.6 million as of December 31, 2020. Financial Outlook: The Company anticipates R&D expenses for 2022 to increase relative to 2021, driven by initiation of the comprehensive Phase 2 program for emraclidine. Cerevel expects G&A expenses for 2022 to increase relative to 2021 to support the expansion and advancement of its pipeline and initiate pre-commercialization activities. The Company’s cash, cash equivalents and marketable securities are expected to continue to support operations into 2024.

For further details see:

Cerevel Therapeutics GAAP EPS of -$0.40
Stock Information
Company Name: Ceres Inc.
Stock Symbol: CERE
Market: NASDAQ
Website: cerevel.com
Menu
CERE CERE Quote CERE Short CERE News CERE Articles CERE Message Board
Get CERE Alerts

News, Short Squeeze, Breakout and More Instantly...